Sensible Biotherapeutics

Manufacturing · New York, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

209 Deer Run, Williamsville, New York, 1...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Sensible Biotherapeutics

Sensible Biotherapeutics is dedicated to developing innovative pharmaceutical products aimed at treating major diseases, with a focus on antiviral therapies and medical technology. The company is actively working on potential COVID-19 treatments and expanding its radiopharmaceutical division to enhance access to PET imaging. They are also pioneering antisense therapy and developing medical devices, including a generator for fluorine-18 production. Led by Dr. Michael A. Meyer, the company combines clinical expertise with cutting-edge research.Explore more
Popular SearchesSensible Biotherapeutics LLCSensible BiotherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Sensible Biotherapeutics Org Chart

PhoneEmail
MM
United States flag for contact location.

Founder & Director

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Sensible Biotherapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Sensible Biotherapeutics

Compare insights from companies similar to Sensible Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Sensible Biotherapeutics

<$5M
1-10
Private
-
2015
MM
Michael MeyerFounder & Director
$8.8M
1-10
Private
-
2017
N/A
$6.2M
11-50
Private
-
-
RM
Ramin MirhadiVice President, International Business Development
<$5M
11-50
Private
-
2003
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
-
JB
Jimmy BalwitFounder & Principal & Consultant
<$5M
1-10
Private
-
2017
VH
Vera HoffmanCEO & Co-Founder
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Sensible Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Sensible Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sensible Biotherapeutics.

Sensible Biotherapeutics Tech Stack

A closer look at the technologies used by Sensible Biotherapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Sensible Biotherapeutics

What is Sensible Biotherapeutics's official website?
Sensible Biotherapeutics's official website is www.sensiblebiotherapeutics.com
What is Sensible Biotherapeutics's Revenue?
Sensible Biotherapeutics's revenue is <$5 Million
What is Sensible Biotherapeutics's SIC code?
Sensible Biotherapeutics's SIC: 28,283
What is Sensible Biotherapeutics's NAICS code?
Sensible Biotherapeutics's NAICS: 32,325
How many employees does Sensible Biotherapeutics have?
Sensible Biotherapeutics has 1-10 employees
What industry does Sensible Biotherapeutics belong to?
Sensible Biotherapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Sensible Biotherapeutics competition?
Sensible Biotherapeutics top competitors include: Nobelpharma America, Reveal Pharmaceuticals, PulseAid, Ahrens Balwit & Associates
What technology does Sensible Biotherapeutics use?
Some of the popular technologies that Sensible Biotherapeutics uses are: Sentry, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager, Google Workspace
What does Sensible Biotherapeutics do?

Sensible Biotherapeutics is dedicated to developing innovative pharmaceutical products aimed at treating major diseases, with a focus on antiviral therapies and medical technology. The company is actively working on potential COVID-19 treatments and expanding its radiopharmaceutical division to enhance access to PET imaging. They are also pioneerin... g antisense therapy and developing medical devices, including a generator for fluorine-18 production. Led by Dr. Michael A. Meyer, the company combines clinical expertise with cutting-edge research.Read More

Is Sensible Biotherapeutics a public company?
Sensible Biotherapeutics is private company therefore does not currently have an official ticker symbol
See more information about Sensible Biotherapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.